FindTrial
Sign In

effect of single herbal drug on white dischagre

Efficacy of Kundur (Boswalliaserrata)in Vulvovaginal Candidiasis;A Randamized Standard Controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017861
Enrollment
40
Registered
2019-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis

Interventions

Intervention1: Kundur (Gum resins of Boswellia serrata): Kundur will be powdered and tablet (1gm) will be made and 1 tablet per vaginally will be given at bed time daily for 21 days. Control Intervent

Sponsors

Nikhat kausar M Inamdar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women between 18 to 45 yearsof ages. 2.Clinically diagnosed cases of vulvovaginal candidiasis.

Exclusion criteria

Exclusion criteria: 1.Pregnant ,lactating and unmarried women. 2.Suspected of having concurrent vaginal infections. 3.Patients having antifungal, antibiotic or corticosteroid therapies within past 2 weeks. 4.Patients with diabetes mellitus. 5.Patients on oral contraceptive pills. 6.Patients having sexually transmitted diseases.

Design outcomes

Primary

MeasureTime frame
1.Improvement in subjective parametersTimepoint: 21 days—

Secondary

MeasureTime frame
1.Improvement in objective parametersTimepoint: 21days—

Countries

India

Contacts

Public ContactDr Mariyam roqaiya

Luqman Unani Medical College

dr.mroqaiya@gmail.com9632560839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026